IPLIA

Serial Number 98087576
731

Registration Progress

Application Filed
Jul 17, 2023
Under Examination
Jan 30, 2024
Approved for Publication
Dec 5, 2023
Published for Opposition
Dec 5, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Jul 30, 2025 11 days

Trademark Image

IPLIA

Basic Information

Serial Number
98087576
Filing Date
July 17, 2023
Published for Opposition
December 5, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Dec 12, 2024
Application
Pending
Classes
005

Rights Holder

Johnson & Johnson

03
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 08933

Ownership History

Johnson & Johnson

Original Applicant
03
New Brunswick, NJ

Johnson & Johnson

Owner at Publication
03
New Brunswick, NJ

Legal Representation

Attorney
Cheryl L. Foytlin

USPTO Deadlines

Next Deadline
11 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
July 30, 2025
Extension Available
Until January 30, 2025

Application History

16 events
Date Code Type Description Documents
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 12, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 12, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 12, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 8, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 8, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 8, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 8, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 30, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 5, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 5, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 15, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 30, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 29, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 15, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 20, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders, digital ulcers

Classification

International Classes
005